Screener
Net margin at other companies
Other financials
Where this comes from
Calculated from Kiniksa Pharmaceuticals International, plc’s reported figures.
Based on trailing twelve months.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026. Open the filing →
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
FAQ
- What is Kiniksa Pharmaceuticals International, plc's net margin?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported net margin of 9.6% in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's net margin changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's net margin increased by 960.1% year-over-year, from 0.9% to 9.6%.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's net margin?
- Over 4 years (2021 to 2025), Kiniksa Pharmaceuticals International, plc's net margin has grown at a -61.8% compound annual growth rate (CAGR), from -409.7% to 8.7%.
- What does net margin mean?
- Net income as a percentage of revenue (trailing twelve months). The bottom-line profitability measure after all costs, interest, and taxes.
Ask your AI about Kiniksa Pharmaceuticals International, plc's net margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude